Metabasis Therapeutics (MBRX) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Metabasis Therapeutics (MBRX)

An SI Board Since April 2004

Posts	SubjectMarks	Bans	Symbol
66	9	0	MBRX

Emcee: michael_f_murphy	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
41	This is the next one for you to keep an eye on.... pharmasset.com They're	rkrw	-	5/4/2007
40	That's too bad, the efficacy data had been very strong. P.S. you sure hav	rkrw	-	5/4/2007
39	Looks like you were unduly bullish on Pradefovir: biz.yahoo.com	DewDiligence_on_SI	-	5/4/2007
38	>>Metabasis Therapeutics Presents Results of a Clinical Study for Its Nove	tuck	-	4/16/2007
37	[MB07133 P1/2 results at AACR] >>A phase I/II study to assess the safety,	tuck	-	4/13/2007
36	Metbasis hypes one if its platform technologies: >>Metabasis Therapeutics	tuck	-	4/12/2007
35	>>Metabasis Therapeutics Initiates a Proof of Concept Study for MB07803, I	tuck	-	4/4/2007
34	[7133 for liver cancer characterized versus cytarabine] >> J Med Chem. 20	tuck	-	2/22/2007
33	library.corporate-ir.net Went through the presentation today. Nothing new! Wait	dr.praveen	-	2/15/2007
32	Might be the latest Nexavar data in Advanced Hepatocellular Ca can get a deal so	dr.praveen	-	2/13/2007
31	Well, the CEO did up the ante a little during the BIO CEO presentation, saying t	tuck	-	2/13/2007
30	Your hard work is paying off today:-)I am a little skeptical about the one for L	dr.praveen	-	2/6/2007
29	[Characterization of Pradefovir] >>J Am Chem Soc. 2004 Apr 28;126(16):515	tuck	-	2/6/2007
28	[Liver targeting of hepatitis-B antiviral lamivudine using the HepDirect prodrug	tuck	-	2/6/2007
27	[CS-917: Inhibition of Fructose 1,6-Bisphosphatase Reduces Excessive Endogenous	tuck	-	2/6/2007
26	Thanks, kenhott; here's my notes: Milestones for '07 CS-917: PIIb resu	tuck	-	2/6/2007
25	Link: mapdigital.com	kenhott	-	2/1/2007
24	>>Metabasis Announces Completion of Enrollment in the Phase 2b Clinical Tr	tuck	-	2/1/2007
23	>>Dr. Paul Laikind, president and chief executive officer. "With resp	tuck	-	1/22/2007
22	I am glad that pradefovir wasn't scrapped:-) Time to move on with the rest o	dr.praveen	-	12/15/2006
21	Thanks. Posting the 3rd Q PR, which contains a recent clinical update, for easy	tuck	-	12/15/2006
20	Nah, I think just a sell on the news and some disappointment it was sgp and not	rkrw	-	12/15/2006
19	Stock has splutted since the R&D presentation Thursday morning. Was there a	tuck	-	12/15/2006
18	Glad to see this out of valeant's hands and into sgp. I think this is a very	rkrw	-	12/13/2006
17	Valeant Pharmaceuticals And Metabasis Therapeutics License Rights To Hepatitis B	LJM	-	12/13/2006

Go to reply# or date (mm/dd/yy):